The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma
Open accessAbstract
SUMMARY Primary central nervous system lymphoma (PCNSL) harbors mutations that reinforce B cell receptor (BCR) signaling. Ibrutinib, a BTK inhibitor, targets BCR signaling and is particularly active in lymphomas with BCR and MYD88 mutations. We performed a proof of concept phase Ib study of ibrutinib monotherapy followed by ibrutinib plus chemotherapy (DA-TEDDi-R). In 18 PCNSL patients, 94% showed tumor reductions with ibrutinib alone, including patients having PCNSL with CD79B and/or MYD88 mutations, and 86% of evaluable patients achieved a complete remission with DA-TEDDi-R. Increased aspergillosis was observed with ibrutinib monotherapy and DA-TEDDi-R. Aspergillosis was linked to BTK-dependent fungal immunity in a murine model. PCNSL is highly dependent on BCR signaling and ibrutinib appears to enhance the efficacy of chemotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
THE TOXICITY OF POISONS APPLIED JOINTLY1
BLISS, C. I. (1939) · Annals of Applied Biology · doi:10.1111/j.1744-7348.1939.tb06990.x · Cited by 2,419
Infection in Solid-Organ Transplant Recipients
Fishman, J. A. (2007) · New England Journal of Medicine · doi:10.1056/nejmra064928 · Cited by 1,950
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
Davis, R. E., Ngo, V. N., Lenz, G., Tolar, P., Young, R. M., Romesser, P. B., Kohlhammer, H., Lamy, L., Zhao, H., Yang, Y., et al. (2010) · Nature · doi:10.1038/nature08638 · Cited by 1,643
Self-citationOncogenically active MYD88 mutations in human lymphoma
Ngo, V. N., Young, R. M., Schmitz, R., Jhavar, S., Xiao, W., Lim, K.-H., Kohlhammer, H., Xu, W., Yang, Y., Zhao, H., et al. (2011) · Nature · doi:10.1038/nature09671 · Cited by 1,512
Self-citationControl of oncogenesis and cancer therapy resistance by the transcription factor NF-κB
Baldwin, A. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11991 · Cited by 1,434
Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma
Wilson, W. H., Young, R. M., Schmitz, R., Yang, Y., Pittaluga, S., Wright, G., Lih, C.-J., Williams, P. M., Shaffer, A. L., Gerecitano, J., et al. (2015) · Nature Medicine · doi:10.1038/nm.3884 · Cited by 1,113
Self-citationPathogenesis of Aspergillus fumigatus in Invasive Aspergillosis
Dagenais, T. R. T., & Keller, N. P. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00055-08 · Cited by 993
Abrey, L. E., Batchelor, T. T., Ferreri, A. J. M., Gospodarowicz, M., Pulczynski, E. J., Zucca, E., Smith, J. R., Korfel, A., Soussain, C., DeAngelis, L. M., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.13.524 · Cited by 914
Dubovsky, J. A., Beckwith, K. A., Natarajan, G., Woyach, J. A., Jaglowski, S., Zhong, Y., Hessler, J. D., Liu, T.-M., Chang, B. Y., Larkin, K. M., et al. (2013) · Blood · doi:10.1182/blood-2013-06-507947 · Cited by 810
Defective B cell development and function in Btk-deficient mice
Khan, W. N., Alt, F. W., Gerstein, R. M., Malynn, B. A., Larsson, I., Rathbun, G., Davidson, L., Müller, S., Kantor, A. B., Herzenberg, L. A., et al. (1995) · Immunity · doi:10.1016/1074-7613(95)90114-0 · Cited by 726
CNS Metastases in Breast Cancer
Lin, N. U., Bellon, J. R., & Winer, E. P. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.01.175 · Cited by 715
Glucocorticoids and invasive fungal infections
Lionakis, M. S., & Kontoyiannis, D. P. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14904-5 · Cited by 669
Self-citationTargetable genetic features of primary testicular and primary central nervous system lymphomas
Chapuy, B., Roemer, M. G. M., Stewart, C., Tan, Y., Abo, R. P., Zhang, L., Dunford, A. J., Meredith, D. M., Thorner, A. R., Jordanova, E. S., et al. (2016) · Blood · doi:10.1182/blood-2015-10-673236 · Cited by 585
Rubenstein, J. L., Hsi, E. D., Johnson, J. L., Jung, S.-H., Nakashima, M. O., Grant, B., Cheson, B. D., & Kaplan, L. D. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.9957 · Cited by 509
Mathews Griner, L. A., Guha, R., Shinn, P., Young, R. M., Keller, J. M., Liu, D., Goldlust, I. S., Yasgar, A., McKnight, C., Boxer, M. B., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1311846111 · Cited by 377
Self-citationPlebani, A., Soresina, A., Rondelli, R., Amato, G. M., Azzari, C., Cardinale, F., Cazzola, G., Consolini, R., De Mattia, D., Dell'Erba, G., et al. (2002) · Clinical Immunology · doi:10.1006/clim.2002.5241 · Cited by 329
Lewis, R. E., Cahyame‐Zuniga, L., Leventakos, K., Chamilos, G., Ben‐Ami, R., Tamboli, P., Tarrand, J., Bodey, G. P., Luna, M., & Kontoyiannis, D. P. (2013) · Mycoses · doi:10.1111/myc.12081 · Cited by 248
Siegal, T., Horowitz, A., & Gabizon, A. (1995) · Journal of neurosurgery · doi:10.3171/jns.1995.83.6.1029 · Cited by 232
Recurrent mutations of CD79B and MYD88 are the hallmark of primary central nervous system lymphomas
Nakamura, T., Tateishi, K., Niwa, T., Matsushita, Y., Tamura, K., Kinoshita, M., Tanaka, K., Fukushima, S., Takami, H., Arita, H., et al. (2016) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12259 · Cited by 227
Braggio, E., Van Wier, S., Ojha, J., McPhail, E., Asmann, Y. W., Egan, J., da Silva, J. A., Schiff, D., Lopes, M. B., Decker, P. A., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2116 · Cited by 222
Efficacy of a Technique for Exposing the Mouse Lung to Particles Aspirated from the Pharynx
Rao, G. V. S., Tinkle, S., Weissman, D., Antonini, J., Kashon, M., Salmen, R., Battelli, L., Willard, P., Hubbs, A., & Hoover, M. (2003) · Journal of Toxicology and Environmental Health, Part A · doi:10.1080/15287390306417 · Cited by 216
Kraan, W., Horlings, H. M., van Keimpema, M., Schilder-Tol, E. J. M., Oud, M. E. C. M., Scheepstra, C., Kluin, P. M., Kersten, M. J., Spaargaren, M., & Pals, S. T. (2013) · Blood Cancer Journal · doi:10.1038/bcj.2013.28 · Cited by 205
Bruton’s Tyrosine Kinase Is Required for TLR2 and TLR4-Induced TNF, but Not IL-6, Production
Horwood, N. J., Page, T. H., McDaid, J. P., Palmer, C. D., Campbell, J., Mahon, T., Brennan, F. M., Webster, D., & Foxwell, B. M. J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.6.3635 · Cited by 203
Langner-Lemercier, S., Houillier, C., Soussain, C., Ghesquières, H., Chinot, O., Taillandier, L., Soubeyran, P., Lamy, T., Morschhauser, F., Benouaich-Amiel, A., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now033 · Cited by 201
Survival of human lymphoma cells requires B-cell receptor engagement by self-antigens
Young, R. M., Wu, T., Schmitz, R., Dawood, M., Xiao, W., Phelan, J. D., Xu, W., Menard, L., Meffre, E., Chan, W.-C. C., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1514944112 · Cited by 191
Self-citationThe role of alveolar macrophages in Pneumocystis carinii degradation and clearance from the lung.
Limper, A. H., Hoyte, J. S., & Standing, J. E. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119384 · Cited by 188
Vail, D. M., Amantea, M. A., Colbern, G. T., Martin, F. J., Hilger, R. A., & Working, P. K. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.08.002 · Cited by 187
Koukourakis, M. I., Koukouraki, S., Fezoulidis, I., Kelekis, N., Kyrias, G., Archimandritis, S., & Karkavitsas, N. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1459 · Cited by 186
Mutational analysis of primary central nervous system lymphoma
Bruno, A., Boisselier, B., Labreche, K., Marie, Y., Polivka, M., Jouvet, A., Adam, C., Figarella-Branger, D., Miquel, C., Eimer, S., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2080 · Cited by 185
Herbst, S., Shah, A., Mazon Moya, M., Marzola, V., Jensen, B., Reed, A., Birrell, M. A., Saijo, S., Mostowy, S., Shaunak, S., et al. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201404556 · Cited by 176
Leopold Wager, C. M., & Wormley, F. L. (2014) · Mucosal Immunology · doi:10.1038/mi.2014.65 · Cited by 172
Vater, I., Montesinos-Rongen, M., Schlesner, M., Haake, A., Purschke, F., Sprute, R., Mettenmeyer, N., Nazzal, I., Nagel, I., Gutwein, J., et al. (2015) · Leukemia · doi:10.1038/leu.2014.264 · Cited by 166
Liu, X., Smith, B. J., Chen, C., Callegari, E., Becker, S. L., Chen, X., Cianfrogna, J., Doran, A. C., Doran, S. D., Gibbs, J. P., et al. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.008201 · Cited by 163
Ramirez‐Ortiz, Z. G., Specht, C. A., Wang, J. P., Lee, C. K., Bartholomeu, D. C., Gazzinelli, R. T., & Levitz, S. M. (2008) · Infection and Immunity · doi:10.1128/iai.00047-08 · Cited by 151
Scheers, E. M., Leclercq, L., de Jong, J., Bode, N., Bockx, M., Laenen, A., Cuyckens, F., Skee, D. M., Murphy, J., Sukbuntherng, J., et al. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.060061 · Cited by 144
Btk Regulates Macrophage Polarization in Response to Lipopolysaccharide
Gabhann, J. N., Hams, E., Smith, S., Wynne, C., Byrne, J. C., Brennan, K., Spence, S., Kissenpfennig, A., Johnston, J. A., Fallon, P. G., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085834 · Cited by 143
Kraan, W., van Keimpema, M., Horlings, H. M., Schilder-Tol, E. J. M., Oud, M. E. C. M., Noorduyn, L. A., Kluin, P. M., Kersten, M. J., Spaargaren, M., & Pals, S. T. (2013) · Leukemia · doi:10.1038/leu.2013.348 · Cited by 120
Dubourdeau, M., Athman, R., Balloy, V., Huerre, M., Chignard, M., Philpott, D. J., Latgé, J., & Ibrahim-Granet, O. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.6.3994 · Cited by 114
Fiedler, K., Sindrilaru, A., Terszowski, G., Kókai, E., Feyerabend, T. B., Bullinger, L., Rodewald, H.-R., & Brunner, C. (2010) · Blood · doi:10.1182/blood-2010-04-281170 · Cited by 113
Anders, C. K., Adamo, B., Karginova, O. A., Deal, A. M., Rawal, S., Darr, D. B., Schorzman, A. N., Santos, C., Bash, R., Kafri, T., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061359 · Cited by 88
Kasperkovitz, P. V., Cardenas, M. L., & Vyas, J. M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002760 · Cited by 75
Ramaprakash, H., Ito, T., Standiford, T. J., Kunkel, S. L., & Hogaboam, C. M. (2008) · Infection and Immunity · doi:10.1128/iai.00998-08 · Cited by 74
Palmer, C. D., Mutch, B. E., Workman, S., McDaid, J., Horwood, N. J., & Foxwell, B. M. J. (2007) · Blood · doi:10.1182/blood-2007-07-102343 · Cited by 73
Caraglia, M., Addeo, R., Costanzo, R., Montella, L., Faiola, V., Marra, M., Abbruzzese, A., Palmieri, G., Budillon, A., Grillone, F., et al. (2005) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-005-0001-z · Cited by 70
Chignard, M., Balloy, V., Sallenave, J., & Si‐Tahar, M. (2007) · Clinical Immunology · doi:10.1016/j.clim.2007.05.004 · Cited by 61
Byrne, J. C., Gabhann, J. N., Stacey, K., Coffey, B. M., McCarthy, E. M., Thomas, W., & Jefferies, C. A. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300057 · Cited by 58
Ibrutinib for Chronic Lymphocytic Leukemia
Sharman, J. P., Mato, A. R., & Keating, M. J. (2016) · New England Journal of Medicine · doi:10.1056/nejmc1600328 · Cited by 53
Stadler, N., Hasibeder, A., Lopez, P. A., et al. (2017) · Haematologica · doi:10.3324/haematol.2016.152017 · Cited by 47
Treatment strategies for aggressive lymphomas: what works?
Wilson, W. H. (2013) · Hematology · doi:10.1182/asheducation-2013.1.584 · Cited by 44
Self-citationde Vries, R., Huang, M. Q., Bode, N., Jejurkar, P., de Jong, J., Sukbuntherng, J., Sips, L., Weng, N., Timmerman, P., & Verhaeghe, T. (2015) · Bioanalysis · doi:10.4155/bio.15.159 · Cited by 39
Ibrutinib in Chronic Lymphocytic Leukemia
Reddy, N. M., & Sethi, T. K. (2015) · International Journal of Hematologic Oncology · doi:10.2217/ijh.15.15 · Cited by 26
Cited by
Genetics and pathogenesis of diffuse large B-cell lymphoma
Schmitz, R., Wright, G. W., Huang, D. W., Johnson, C. A., Phelan, J. D., Wang, J. Q., Roulland, S., Kasbekar, M., Young, R. M., Shaffer, A. L., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1801445 · Cited by 2,241
Self-citationAspergillus fumigatus and Aspergillosis in 2019
Latgé, J.-P., & Chamilos, G. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00140-18 · Cited by 1,400
Wright, G. W., Huang, D. W., Phelan, J. D., Coulibaly, Z. A., Roulland, S., Young, R. M., Wang, J. Q., Schmitz, R., Morin, R. D., Tang, J., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.03.015 · Cited by 1,169
Self-citationA multiprotein supercomplex controlling oncogenic signalling in lymphoma
Phelan, J. D., Young, R. M., Webster, D. E., Roulland, S., Wright, G. W., Kasbekar, M., Shaffer, A. L., Ceribelli, M., Wang, J. Q., Schmitz, R., et al. (2018) · Nature · doi:10.1038/s41586-018-0290-0 · Cited by 398
Self-citationImmune responses to human fungal pathogens and therapeutic prospects
Lionakis, M. S., Drummond, R. A., & Hohl, T. M. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00826-w · Cited by 379
Self-citation
Metadata
- Authors
- Lionakis, M. S., Dunleavy, K., Roschewski, M., Widemann, B. C., Butman, J. A., Schmitz, R., Yang, Y., Cole, D. E., Melani, C., Higham, C. S., Desai, J. V., Ceribelli, M., Chen, L., Thomas, C. J., Little, R. F., Gea-Banacloche, J., Bhaumik, S., Stetler-Stevenson, M., Pittaluga, S., Jaffe, E. S., Heiss, J., Lucas, N., Steinberg, S. M., Staudt, L. M., & Wilson, W. H.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2017-06
- Volume
- 31
- Issue
- 6
- Pages
- 833-843.e5
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2617968907
- Cited by
- 508
- References
- 51
- FWCI
- 33.19
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.